XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Class C non-voting common stock
Preferred Stock
Preferred Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Class C non-voting common stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Class C non-voting common stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Class C non-voting common stock
Beginning balance ( in shares) at Dec. 31, 2019         9,400 9,400 10,712 10,712                    
Beginning balance at Dec. 31, 2019 $ 799,276 $ (2,099) $ 797,177   $ 228,374 $ 228,374 $ 10,712 $ 10,712   $ 119,304 $ 119,304   $ (16,161) $ (16,161) $ 457,047 $ (2,099) $ 454,948  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net Income 12,830                           12,830      
Other comprehensive loss, net of tax (105,276)                       (105,276)          
Cash dividends, preferred stock (3,431)                           (3,431)      
Cash dividends, common stock (8,571)                           (8,571)      
Issuance of common stock (in shares)                 15                  
Issuance of common stock       $ 34         $ 15     $ 19            
Repurchase of Class C Common Stock (in shares)                 (4)                  
Repurchase of Class C Common Stock       (235)         $ (4)                 $ (231)
Stock-based compensation cost 1,293                 1,293                
Other stock-based award activity (204)                 (204)                
Ending balance (in shares) at Mar. 31, 2020         9,400   10,723                      
Ending balance at Mar. 31, 2020 693,617       $ 228,374   $ 10,723     120,412     (121,437)   455,545      
Beginning balance ( in shares) at Dec. 31, 2020         14,980   10,737                      
Beginning balance at Dec. 31, 2020 992,477       $ 363,204   $ 10,737     122,899     (13,923)   509,560      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net Income 33,227                           33,227      
Other comprehensive loss, net of tax 65,667                       65,667          
Cash dividends, preferred stock (5,269)                           (5,269)      
Cash dividends, common stock (9,450)                           (9,450)      
Issuance of common stock (in shares)                 21                  
Issuance of common stock       $ 33         $ 21     $ 12            
Stock-based compensation cost 1,665                 1,665                
Other stock-based award activity (858)                 (858)                
Ending balance (in shares) at Mar. 31, 2021         14,980   10,758                      
Ending balance at Mar. 31, 2021 $ 1,077,492       $ 363,204   $ 10,758     $ 123,718     $ 51,744   $ 528,068